Trial Profile
Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary) ; Peginterferon alfa; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 05 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 29 Jan 2013 New trial record